日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer

通过对人胰腺癌进行单细胞RNA测序揭示成纤维细胞的动态演变

Dimitrieva, Slavica; Harrison, Jon M; Chang, Jonathan; Piquet, Michelle; Mino-Kenudson, Mari; Gabriel, Millicent; Sagar, Vivek; Horn, Heiko; Lage, Kasper; Kim, Julie; Li, Gang; Weng, Shaobu; Harris, Cynthia; Kulkarni, Anupriya S; Ting, David T; Qadan, Motaz; Fagenholz, Peter J; Ferrone, Cristina R; Grauel, Angelo L; Laszewski, Tyler; Raza, Alina; Riester, Markus; Somerville, Tim; Wagner, Joel P; Dranoff, Glenn; Engelman, Jeffrey A; Kauffmann, Audrey; Leary, Rebecca; Warshaw, Andrew L; Lillemoe, Keith D; Fernández-Del Castillo, Carlos; Ruddy, David A; Liss, Andrew S; Cremasco, Viviana

A landscape of response to drug combinations in non-small cell lung cancer

非小细胞肺癌药物联合治疗反应概况

Nair, Nishanth Ulhas; Greninger, Patricia; Zhang, Xiaohu; Friedman, Adam A; Amzallag, Arnaud; Cortez, Eliane; Sahu, Avinash Das; Lee, Joo Sang; Dastur, Anahita; Egan, Regina K; Murchie, Ellen; Ceribelli, Michele; Crowther, Giovanna S; Beck, Erin; McClanaghan, Joseph; Klump-Thomas, Carleen; Boisvert, Jessica L; Damon, Leah J; Wilson, Kelli M; Ho, Jeffrey; Tam, Angela; McKnight, Crystal; Michael, Sam; Itkin, Zina; Garnett, Mathew J; Engelman, Jeffrey A; Haber, Daniel A; Thomas, Craig J; Ruppin, Eytan; Benes, Cyril H

Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

撤稿声明:EGFR和MET受体酪氨酸激酶改变的microRNA表达诱导肺癌肿瘤发生和吉非替尼耐药性

Garofalo, Michela; Romano, Giulia; Di Leva, Gianpiero; Nuovo, Gerard; Jeon, Young-Jun; Ngankeu, Apollinaire; Sun, Jin; Lovat, Francesca; Alder, Hansjuerg; Condorelli, Gerolama; Engelman, Jeffrey A; Ono, Mayumi; Rho, Jin Kyung; Cascione, Luciano; Volinia, Stefano; Nephew, Kenneth P; Croce, Carlo M

The present and future of PI3K inhibitors for cancer therapy

PI3K抑制剂在癌症治疗中的现状与未来

Castel, Pau; Toska, Eneda; Engelman, Jeffrey A; Scaltriti, Maurizio

Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer

无细胞DNA可捕获预处理转移性癌症快速尸检中的肿瘤异质性和驱动基因改变

Pereira, Bernard; Chen, Christopher T; Goyal, Lipika; Walmsley, Charlotte; Pinto, Christopher J; Baiev, Islam; Allen, Read; Henderson, Laura; Saha, Supriya; Reyes, Stephanie; Taylor, Martin S; Fitzgerald, Donna M; Broudo, Maida Williams; Sahu, Avinash; Gao, Xin; Winckler, Wendy; Brannon, A Rose; Engelman, Jeffrey A; Leary, Rebecca; Stone, James R; Campbell, Catarina D; Juric, Dejan

A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts

基于患者来源肿瘤异种移植的生物标志物指导的卵巢癌靶向治疗概念验证

Palmer, Adam C; Plana, Deborah; Gao, Hui; Korn, Joshua M; Yang, Guizhi; Green, John; Zhang, Xiamei; Velazquez, Roberto; McLaughlin, Margaret E; Ruddy, David A; Kowal, Colleen; Muszynski, Julie; Bullock, Caroline; Rivera, Stacy; Rakiec, Daniel P; Elliott, GiNell; Fordjour, Paul; Meyer, Ronald; Loo, Alice; Kurth, Esther; Engelman, Jeffrey A; Bitter, Hans; Sellers, William R; Williams, Juliet A; Sorger, Peter K

Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer

肺癌中T790M和T790野生型耐药亚克隆的异质性和共存导致对第三代表皮生长因子受体抑制剂的混合反应

Piotrowska, Zofia; Hazar-Rethinam, Mehlika; Rizzo, Coleen; Nadres, Brandon; Van Seventer, Emily E; Shahzade, Heather A; Lennes, Inga T; Iafrate, Anthony J; Dias-Santagata, Dora; Leshchiner, Ignaty; Jessop, Nicholas A; Hu, Haichuan; Digumarthy, Subba R; Nagy, Rebecca J; Lanman, Richard B; Moody, Susan; Niederst, Matthew J; Engelman, Jeffrey A; Hata, Aaron N; Corcoran, Ryan B; Sequist, Lecia V

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation

脑微环境通过HER3激活介导管腔型乳腺癌对PI3K抑制剂的耐药性。

Kodack, David P; Askoxylakis, Vasileios; Ferraro, Gino B; Sheng, Qing; Badeaux, Mark; Goel, Shom; Qi, Xiaolong; Shankaraiah, Ram; Cao, Z Alexander; Ramjiawan, Rakesh R; Bezwada, Divya; Patel, Bhushankumar; Song, Yongchul; Costa, Carlotta; Naxerova, Kamila; Wong, Christina S F; Kloepper, Jonas; Das, Rita; Tam, Angela; Tanboon, Jantima; Duda, Dan G; Miller, C Ryan; Siegel, Marni B; Anders, Carey K; Sanders, Melinda; Estrada, Monica V; Schlegel, Robert; Arteaga, Carlos L; Brachtel, Elena; Huang, Alan; Fukumura, Dai; Engelman, Jeffrey A; Jain, Rakesh K

Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

更正:KEAP1缺失调节肺癌对激酶靶向治疗的敏感性

Krall, Elsa Beyer; Wang, Belinda; Munoz, Diana M; Ilic, Nina; Raghavan, Srivatsan; Niederst, Matthew J; Yu, Kristine; Ruddy, David A; Aguirre, Andrew J; Kim, Jong Wook; Redig, Amanda J; Gainor, Justin F; Williams, Juliet A; Asara, John M; Doench, John G; Janne, Pasi A; Shaw, Alice T; McDonald Iii, Robert E; Engelman, Jeffrey A; Stegmeier, Frank; Schlabach, Michael R; Hahn, William C

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

ALK重排肺癌对第一代和第二代ALK抑制剂产生耐药性的分子机制

Gainor Justin F, Dardaei Leila, Yoda Satoshi, Friboulet Luc, Leshchiner Ignaty, Katayama Ryohei, Dagogo-Jack Ibiayi, Gadgeel Shirish, Schultz Katherine, Singh Manrose, Chin Emily, Parks Melissa, Lee Dana, DiCecca Richard H, Lockerman Elizabeth, Huynh Tiffany, Logan Jennifer, Ritterhouse Lauren L, Le Long P, Muniappan Ashok, Digumarthy Subba, Channick Colleen, Keyes Colleen, Getz Gad, Dias-Santagata Dora, Heist Rebecca S, Lennerz Jochen, Sequist Lecia V, Benes Cyril H, Iafrate A John, Mino-Kenudson Mari, Engelman Jeffrey A, Shaw Alice T